How A Medicare Payment ‘Loophole’ Boosts Spending On Orencia, Cimza
HHS Office of Inspector General renews recommendation that Medicare exclude prices for self-administered versions of drugs reimbursed under Part B in report focused on overpayments for two autoimmune treatments.
You may also be interested in...
Medicare Part B payment loopholes also targeted in law, and Medicare Part D plans will need to offer real-time benefit tools for prescriber-patient decision making.
Mark McClellan discusses whether CMS’s pending final version of the Medicare national coverage determination on Alzheimer’s drugs might change from the draft and whether the decision should be viewed as a precedent for drugs granted accelerated approvals.
Pharmacy organization urges the Centers for Medicare and Medicaid Services to recommend a dispensing fee commensurate with the effort involved in filling scripts for the drugs.